100 ns Molecular Dynamics Simulation of Ozempic (Semaglutide) Bound to the GLP-1 Receptor
Here’s a molecular dynamics simulation I ran of semaglutide, the active ingredient in Ozempic, bound to the GLP-1 receptor.
This is a 100-nanosecond molecular dynamics simulation showing how the peptide and receptor move and interact over time. Unlike a static crystal structure, MD allows us to observe protein flexibility, ligand motion, and changes in the binding environment.
GLP-1 receptor activation plays an important role in insulin secretion, appetite regulation, and blood glucose control, making it a major therapeutic target for type 2 diabetes and obesity.
The video is generated from my actual MD trajectory, not an AI-generated animation. It’s a visualization of the molecular motion predicted during the simulation, rather than a direct recording of molecules.
Thought this community might enjoy seeing what a drug–receptor complex looks like in motion!